Optimisation of oligonucleotide separations using YMC´s non porous anion exchanger BioPro IEX QF

contributed by YMC | 01/24/2020

Nucleic acid therapeutics such as antisense, siRNA and aptamers are expected to play an important role as the next-generation pharmaceuticals together with antibody drugs. These drugs demand chromatographic purification and analysis that can recognize slight structural differences following synthesis. In this report, useful tips for optimisation of ion exchange chromatography methods for oligonucleotides are provided.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.